According to the latest report by IMARC Group, titled “D-dimer Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global D-dimer testing market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the global D-dimer testing market to grow at a CAGR of around 4% during the forecast period (2021-2026). D-dimer testing is the blood test used for the identification of deep vein thrombosis (DVT), disseminated intravascular coagulation (DIC) and pulmonary embolism. The tests are conducted to detect the presence of D-dimer in the blood and locate any chronic clots in the body. D-dimer tests are usually conducted in hospitals, laboratories, and diagnostic centers.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request Free Sample Report: https://www.imarcgroup.com/d-dimer-testing-market/requestsample
The global D-dimer testing market is primarily driven by the increasing prevalence of chronic medical diseases, such as atrial fibrillation, coronary artery disease and acute pancreatitis. Furthermore, the growing geriatric population, who are more susceptible to such ailments, and the rising consumer health consciousness are providing a thrust to the market growth. Moreover, several technological advancements, such as the development of next-generation Point-of-Care (PoC) D-dimer testing solutions, that offer improved accuracy and reduced the waiting time, are acting as other growth-inducing factors. Furthermore, the diagnostic centers are broadly using aptamers that minimize the requirement of antibodies for D-dimer testing and are cost-effective, thereby creating a positive outlook for the global market. Various other factors, including rising healthcare expenditure capacities of the consumers, along with extensive R&D activities, will continue to propel the market growth in the coming years.
Explore Full Report with TOC & List of Figure: https://bit.ly/3uQCWXl
Key Market Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Abbott Laboratories
- BioMedica Diagnostics
- biomérieux SA
- Diazyme Laboratories Inc. (General Atomics)
- Hoffmann-La Roche Ltd.
- HORIBA Ltd.
- Quidel Corporation
- Sekisui Diagnostics LLC (Sekisui Chemical Co. Ltd.)
- Siemens Healthcare GmbH
- Thermo Fisher Scientific Inc.
- Unbound Medicine Inc
Breakup by Test Type:
- Clinical Laboratory Tests
- Point-of-Care Tests
Breakup by Product:
- Reagents and Consumables
Breakup by Method:
- Enzyme-linked Immunosorbent Assay (ELISA)
- Latex-enhanced Immunoturbidimetric Assays
- Fluorescence Immunoassays
Breakup by Application:
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism (PE)
- Disseminated Intravascular Coagulation (DIC)
Breakup by End Use:
- Academic and Research Institutes
- Diagnostic Centers
Breakup by Region:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021- 2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: [email protected]
Follow us on twitter: @imarcglobal
Other Reports by IMARC Group:https://bisouv.com/